Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)

SEK 55.8

(1.82%)

Gross Profit Summary of Infant Bacterial Therapeutics AB (publ)

  • Infant Bacterial Therapeutics AB (publ)'s latest annual gross profit in 2023 was 77 Thousand SEK , up 541.67% from previous year.
  • Infant Bacterial Therapeutics AB (publ)'s latest quarterly gross profit in 2024 Q2 was - SEK , down -100.0% from previous quarter.
  • Infant Bacterial Therapeutics AB (publ) reported a annual gross profit of 12 Thousand SEK in annual gross profit 2022, down 0.0% from previous year.
  • Infant Bacterial Therapeutics AB (publ) reported a annual gross profit of - SEK in annual gross profit 2021, down 0.0% from previous year.
  • Infant Bacterial Therapeutics AB (publ) reported a quarterly gross profit of 5000.00 SEK for 2024 Q1, down 0.0% from previous quarter.
  • Infant Bacterial Therapeutics AB (publ) reported a quarterly gross profit of - SEK for 2023 Q2, down -100.0% from previous quarter.

Annual Gross Profit Chart of Infant Bacterial Therapeutics AB (publ) (2023 - 2012)

Historical Annual Gross Profit of Infant Bacterial Therapeutics AB (publ) (2023 - 2012)

Year Gross Profit Gross Profit Growth
2023 77 Thousand SEK 541.67%
2022 12 Thousand SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 100.0%
2019 -816 Thousand SEK 0.0%
2018 -816 Thousand SEK -442.86%
2017 238 Thousand SEK 136.67%
2016 -649 Thousand SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%

Peer Gross Profit Comparison of Infant Bacterial Therapeutics AB (publ)

Name Gross Profit Gross Profit Difference
Calliditas Therapeutics AB (publ) 1.12 Billion SEK 99.993%
AcouSort AB (publ) 8.38 Million SEK 99.082%
Active Biotech AB (publ) -1.67 Million SEK 104.597%
Alzinova AB (publ) 19.87 Million SEK 99.613%
Amniotics AB (publ) -1.93 Million SEK 103.99%
Asarina Pharma AB (publ) -423 Thousand SEK 118.203%
BioArctic AB (publ) 346.31 Million SEK 99.978%
Camurus AB (publ) 1.58 Billion SEK 99.995%
Cantargia AB (publ) -3.45 Million SEK 102.231%
Scandinavian ChemoTech AB (publ) 1.65 Million SEK 95.356%
Elicera Therapeutics AB (publ) 11.21 Million SEK 99.314%
Genovis AB (publ.) 54 Million SEK 99.857%
Guard Therapeutics International AB (publ) -15 Thousand SEK 613.333%
Mendus AB (publ) 28.48 Million SEK 99.73%
Kancera AB (publ) -1.96 Million SEK 103.919%
Karolinska Development AB (publ) 2.8 Million SEK 97.257%
LIDDS AB (publ) -12.92 Million SEK 100.596%
Lipum AB (publ) 53 Thousand SEK -45.283%
Lipigon Pharmaceuticals AB (publ) -5.11 Million SEK 101.505%
Magle Chemoswed Holding AB (publ) 9.96 Million SEK 99.227%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
NextCell Pharma AB -43.74 Million SEK 100.176%
OncoZenge AB (publ) 3000.00 SEK -2466.667%
Saniona AB (publ) 11.78 Million SEK 99.346%
Simris Alg AB (publ) 2 Million SEK 96.163%
Vicore Pharma Holding AB (publ) -3.42 Million SEK 102.251%
Xbrane Biopharma AB (publ) 35.38 Million SEK 99.782%
Xintela AB (publ) 78 Thousand SEK 1.282%
Ziccum AB (publ) -23.28 Million SEK 100.331%
Isofol Medical AB (publ) -34.41 Million SEK 100.224%
Xspray Pharma AB (publ) -9.19 Million SEK 100.838%
CombiGene AB (publ) -21.29 Million SEK 100.362%
Diamyd Medical AB (publ) -3.58 Million SEK 102.151%
Intervacc AB (publ) -13.79 Million SEK 100.558%
Alligator Bioscience AB (publ) -160.68 Million SEK 100.048%
Sprint Bioscience AB (publ) 41.78 Million SEK 99.816%
QuiaPEG Pharmaceuticals Holding AB (publ) 2.17 Million SEK 96.453%
Corline Biomedical AB 28.38 Million SEK 99.729%
IRLAB Therapeutics AB (publ) -122.73 Million SEK 100.063%
Bio-Works Technologies AB (publ) 26.82 Million SEK 99.713%
Aptahem AB (publ) 2.63 Million SEK 97.073%
Fluicell AB (publ) 1.73 Million SEK 95.57%
Biovica International AB (publ) 6.87 Million SEK 98.88%
Spago Nanomedical AB (publ) -23.28 Million SEK 100.331%
Abliva AB (publ) -35.66 Million SEK 100.216%
Egetis Therapeutics AB (publ) -146.9 Million SEK 100.052%
2cureX AB (publ) -37.48 Million SEK 100.205%
I-Tech AB 27.56 Million SEK 99.721%
Hansa Biopharma AB (publ) 70.95 Million SEK 99.891%
Cyxone AB (publ) 2.61 Million SEK 97.051%
ExpreS2ion Biotech Holding AB (publ) 3.4 Million SEK 97.737%
Biosergen AB -456 Thousand SEK 116.886%
Nanologica AB (publ) -76 Thousand SEK 201.316%
SynAct Pharma AB -778 Thousand SEK 109.897%
Annexin Pharmaceuticals AB (publ) -193 Thousand SEK 139.896%
BioInvent International AB (publ) 71.46 Million SEK 99.892%
Stayble Therapeutics AB (publ) - SEK -Infinity%
Oncopeptides AB (publ) 36.29 Million SEK 99.788%
Pila Pharma AB (publ) 1.46 Million SEK 94.737%
Ascelia Pharma AB (publ) -1.04 Million SEK 107.34%
Diagonal Bio AB (publ) 3.13 Million SEK 97.542%